The oxidative modification of low density lipoprotein (LDL) may play an important role in atherosclerosis. We found that the antioxidant N,N'-diphenyl-1,4-phenylenediamine (DPPD) inhibits in vitro LDL oxidation at concentrations much lower than other reported antioxidants. To test whether DPPD could prevent atherosclerosis, New Zealand White rabbits were fed either a diet containing 0.5% cholesterol and 10% corn oil (control group) or the same diet also containing 1% DPPD (DPPDfed group) for 10 wk. Plasma total cholesterol levels were not different between the two groups, but DPPD feeding increased the levels of triglyceride (73%, P = 0.007) and HDL cholesterol (26%, P = 0.045). Lipoproteins from DPPD-fed rabbits contained DPPD and were much more resistant to oxidation than control lipoproteins. After 10 wk, the DPPD-fed animals had less severe atherosclerosis than did the control animals: thoracic aorta lesion area was decreased by 71% (P = 0.0007), and aortic cholesterol content was decreased by 51% (P = 0.007). Although DPPD cannot be given to humans because it is a mutagen, our results indicate that orally active antioxidants can have antiatherosclerotic activity. This strongly supports the theory that oxidized LDL plays an important role in the pathogenesis of atherosclerosis. (J. Clin. Invest. 1992. 89:1885-1891
Introduction
A prominent feature of atherosclerotic lesions is the cholesterol-loaded macrophage foam cell (1) . During the progression ofatherosclerosis, circulating monocytes adhere to the endothelium, penetrate the vessel wall, differentiate into macrophages, and become cholesterol-loaded (2) . Low density lipoprotein (LDL) is believed to be the source of the cholesterol in foam cells, and LDL levels are positively correlated with risk of atherosclerosis and coronary artery disease (3) . Conversely, HDL levels are negatively correlated with this disease (4) , and HDL particles are believed to be able to accept excess cholesterol from foam cells and deliver this cholesterol to the liver via the reverse cholesterol transport pathway (5) .
A model has been proposed for the biochemical mechanism by which LDL causes the appearance of foam cells (6) . The "oxidized LDL hypothesis" states that atherosclerosis is caused not only by the native LDL particle itself, but by a modified LDL created by oxidative damage (6) . LDL can be oxidatively modified in vitro by certain cultured cells (7) (8) (9) or by copper ions (7) . Oxidized LDL is taken up via macrophage scavenger receptors (10) , leading to cholesterol accumulation (6) , whereas native LDL is not recognized by scavenger receptors and therefore does not cause cholesterol accumulation (11) . Oxidized LDL is chemotactic for monocytes (12) , and therefore oxidized LDL may recruit monocytes into the subendothelial space. Oxidized LDL is also cytotoxic (8) , which may explain the endothelial damage that occurs during atherogenesis (13) . Most studies of the in vitro effects of oxidized LDL have used LDL subjected to strong oxidizing conditions, but even "minimally modified" LDL has potent biological activity (14) . These in vitro results support a role for oxidized LDL in the recruitment of monocytes into the artery and their conversion to cholesterol-loaded foam cells.
LDL oxidative modification probably occurs in vivo. Immunohistochemical studies suggest that atherosclerotic lesions contain oxidized LDL (15) (16) (17) , and a modified form of LDL can be isolated from dissected lesions (18) . Normal arterial tissue, however, contains no modified LDL (16) , so it is conceivable that the modified LDL found in lesions is a consequence, rather than a cause, of atherosclerosis.
Among the most important in vivo evidence in support of the so-called "oxidized LDL hypothesis" comes from studies using probucol (4,4'4isopropylidenedithio) bis [2,6-di-t-butylphenol] . Probucol is used clinically to lower plasma cholesterol levels (19) , but probucol is also an antioxidant and was found to protect LDL from oxidative modification in vitro (20) . Furthermore, lipoproteins isolated from humans or rabbits given probucol display increased resistance to oxidation ex vivo (20, 21) . Most importantly, probucol slows the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit to an extent greater than that predicted from its cholesterol-lowering activity (22) . Probucol has also been reported to be antiatherosclerotic in the cholesterol-fed rabbit (reviewed in reference 23).
It has been widely assumed that the antiatherosclerotic activity of probucol is due to its antioxidant properties (6, 23) .
Very recent work by Mao et al. (24) however, has raised some doubts. These workers studied the compound MDL 29,31 1, which is an analogue of probucol that does not lower cholesterol but does have full antioxidant activity. MDL 29,31 1 was found to be much less effective than probucol at preventing atherosclerosis in the Watanabe rabbit (24) . This implies that the antioxidant activity ofprobucol may not be the source ofits antiatherosclerotic activity. It is possible that probucol is antiatherosclerotic because of its effects on high density lipoprotein (HDL) metabolism (19) , especially the distribution of HDL subclasses (25, 26) . These effects of probucol on HDL may lead to stimulation of reverse cholesterol transport (26, 27) . In patients with familial hypercholesterolemia, probucol caused dramatic regression oftendon xanthomas (25). The extent ofthe regression correlated with the degree of HDL lowering, suggesting that the regression may be caused by probucol's influence on HDL metabolism (25). Finally, it has been suggested that probucol's antiatherosclerotic activity may be related to inhibition of interleukin 1 (IL-1) secretion by macrophages (28, 29) .
The oxidized LDL hypothesis could be further tested in animal models of atherosclerosis by using potent, orally active antioxidants that do not alter plasma cholesterol levels. The compound NN'-diphenyl-1,4-phenylenediamine (DPPD)' is an orally active antioxidant (30) (31) (32) (33) . Diets containing DPPD can prevent or alleviate symptoms of vitamin E deficiency in rabbits (31) and rats (32, 33) . In the present work, we show that DPPD very effectively prevents oxidation of LDL, and also that feeding DPPD slows the progression of atherosclerosis in cholesterol-fed rabbits without affecting plasma cholesterol levels.
Methods
Animals and treatments. Pasteurella-free male New Zealand White rabbits (2.5 kg) were obtained from Hare Marland, Hewitt, NJ, and housed and cared for as set forth in the Animal Welfare Act. 14 control rabbits were fed a chow containing 10% corn oil and 0.5% cholesterol, and 12 DPPD-fed rabbits were given the same diet containing 1% DPPD (Aldrich Chemical Co., Milwaukee, WI). This dose is the same as the dose of probucol typically given to rabbits (21) (22) (23) . The diets were prepared by milling Purina high-fiber rabbit pellets with corn oil and cholesterol, with or without DPPD, to produce a homogeneous coarse powder. Rabbits were fed ad libitum. The animals were bled periodically for measurements of plasma cholesterol levels. After 27 d of feeding, fasting plasmas were obtained and analyzed for triglyceride and for the distribution ofcholesterol in lipoprotein fractions. Lipoproteins isolated from these plasma samples and from samples taken after 62 d of feeding were subjected to oxidation assays as described below.
Analysis ofextent ofatherosclerosis. After 71 d of feeding, the rabbits were killed and the aortas were removed, rinsed in saline, cleaned of adhering tissue, and trimmed to include the region from the aortic root to 1 cm below the superior mesenteric artery. The aortas were sliced open longitudinally, photographed, and then finely minced. Lesion area in the thoracic region (from the distal end ofthe aortic arch to the mesenteric artery) was determined from the photographs by quantitative morphometric analysis using a Joyce-Lobel Magiscan image analyzer (Compix Inc., Mars, PA). The minced aortic tissue was weighed, then extracted as described by Folch et al. (34) . Aliquots ofthe extracts were subjected to silica gel thin-layer chromatography in the solvent system hexane/diethyl ether/acetic acid 80:20:1. Regions of free cholesterol and esterified cholesterol were scraped and lipids were extracted from the silica gel using chloroform:methanol 1:1. These extracts were subjected to the cholesterol assay described by Rudell and Morris (35) . This procedure yields values for free cholesterol and for 1. Abbreviations used in this paper: BHT, butylated hydroxytoluene; DPPD, NN'-diphenyl-l,4-phenylenediamine; fl-VLDL, E-migrating very low density lipoprotein; d < 1.0 19, the lipoprotein fraction with a density < 1.0 19 g/ml; TBARS, thiobarbituric acid-reactive substances. esterified cholesterol; these values were added together to obtain a value for total cholesterol.
Lipoprotein isolation and assays of lipoprotein oxidation. Blood was collected using EDTA as the anticoagulant, and plasma was obtained by centrifugation. To measure the distribution of cholesterol in lipoprotein fractions, 200-,dl aliquots ofplasma were diluted to 1.0 ml, adjusted to appropriate densities and centrifuged in a model TL-100 ultracentrifuge (Beckman Instruments, Inc., Fullerton, CA). The tube was cut in half, and cholesterol was measured in the upper and lower fractions.
For preparative isolation of rabbit lipoproteins, aliquots of plasma were pooled to create three independent plasma samples from each group of rabbits (control and DPPD-fed). These samples were used to isolate lipoproteins in the density ranges d < 1.0 19 g/ml and 1.019 < d < 1.063 (LDL) by standard procedures (36). The d < 1.019 fraction includes all of the fl-VLDL, which is a major component of lipoproteins in the cholesterol-fed rabbit (37) . All ultracentrifugation buffers included 1 mM EDTA to prevent oxidation. After isolation, the lipoproteins were dialyzed against phosphate-buffered saline containing no EDTA, then sterile filtered, and analyzed for cholesterol and DPPD content (see below). Rabbit lipoproteins (400 Mg of cholesterol/ml) were subjected to oxidation by incubation at 370C in F-10 medium containing 10 ,M CuSO4 (7). At various times, samples were assayed for the presence ofthiobarbituric acid-reactive substances (TBARS) as described (38) except the color was quantitated by measuring fluoresence at an excitation wavelength of 515 nm and emmission wavelength of 553 nm (39) . Results are expressed as nanomoles of malondialdehyde equivalents per milligram of lipoprotein cholesterol. In some experiments, the ability ofoxidized lipoproteinsto bind to macrophage scavenger receptors was assessed by measuring inhibition ofmacrophage uptake of radioiodinated oxidized human LDL. Human LDL was radioiodinated using the trapped ligand tyramine cellobiose (40) , then oxidized with 10MM CuSO4. This oxidized '25I-LDL (5Mug cholesterol/ml) was incubated with mouse peritoneal macrophages for 5 h at 37°C in the presence or absence ofrabbit lipoproteins (250 Mg ofcholesterol/ml) previously subjected to oxidation. Uptake was measured by quantitating cell-associated 125I as previously described (10) .
Human LDL was isolated from plasma of normal volunteers by standard procedures (36) . Cellular modification ofLDL was performed using the RECB4 line of rabbit aortic endothelial cells (obtained from D. Steinberg, San Diego) as previously described (10) . The extent of oxidation was measured by the TBARS assay, as described above. In some cases, inhibitors were added at various concentrations, and the concentration required for 50% inhibition (EC50) was (45) . The hydrogen atom quenches other, more reactive radicals, and thereby terminates free radical chain reactions (45) . We tested a number of compounds related to DPPD to elucidate the structural requirements for antioxidant activity (Fig. 1) . The terminal phenyl groups ofDPPD (compound I) are important: insertion of methylene groups between the nitrogens and the phenyl rings (compound II) slightly increased EC50, and replacing the phenyl groups with methyl groups (compound III) increased EC50 about fivefold. Simplified versions ofDPPD were not nearly as effective: phenylenediamine (IV) and diphenylamine (V) have EC50's > 1 MM.
The para arrangement of the nitrogens in DPPD is essential; the meta analogue of DPPD (compound VII) is inactive. The nitrogens of DPPD are also essential; replacing them with carbon (VIII) or sulphur (IX) destroys antioxidant activity.
These results lead us to conclude that DPPD is an effective antioxidant because it can lose one hydrogen atom from each nitrogen, and become NN'-diphenyl-1,4-quinoneimide. This chemistry is analogous to reactions of hydroquinone (compound VI, Fig. 1 ), which itself is an antioxidant, although a much weaker antioxidant than DPPD.
Analyses ofplasma ofrabbitsfed cholesterol or cholesterol plus DPPD. To test the oxidized LDL hypothesis ofatherosclerosis, we tested the ability of DPPD to prevent atherosclerosis in the cholesterol-fed rabbit model. 14 New Zealand White rabbits were fed a diet containing 0.5% cholesterol and 10% corn oil ("control rabbits") and 12 rabbits were fed the same diet also containing 1% DPPD ("DPPD-fed"). Both groups of rabbits gained weight during the study; the control rabbits started at 2.6±0.06 kg and their weight increased by 33±3%, and the DPPD-fed rabbits started at 2.5±0.11 kg and their weight increased by 24±4% (these differences were not statistically significant). Plasma cholesterol levels increased during the study for both groups of rabbits (Fig. 2) . Cholesterol exposure for each rabbit was calculated as the area under the curve of plasma cholesterol versus time. Cholesterol exposure for the Lipoproteins from rabbitsfed DPPD are resistant to oxidation ex vivo. Lipoproteins were isolated from rabbits in each treatment group and subjected to oxidizing conditions as described in Methods. Lipoproteins from DPPD-fed rabbits were much more resistant to oxidation than lipoproteins from control rabbits, both at 27 d (Table III) and at 62 d (Fig. 3) . The time course of oxidation in Fig. 3 shows that the lipoproteins from DPPD-fed rabbits eventually are oxidized, i.e., the DPPD in the lipoproteins dramatically increases the lag time ofoxidation. Previous work has shown that antioxidants such as vitamin E also increase lag time for oxidation of LDL (46, 47) .
The absolute value of TBARS produced during 24-h CuS04 oxidation of control rabbit lipoproteins was variable (data not shown; also compare Table III and Fig. 3 ). This variability may arise because of variability in the time course of oxidation: maximum TBARS may not always have been achieved after 24 h of incubation with CuS04. We did find, however, that oxidation of LDL from control rabbits led to recognition by the macrophage scavenger receptor (Fig. 3 B) , whereas LDL from DPPD-fed rabbits was not readily converted to a scavenger receptor ligand (Fig. 3 B) .
LDL from DPPD-fed rabbits prevents oxidation ofhuman LDL. We found that the DPPD present in LDL from DPPDfed rabbits could prevent the oxidation ofhuman LDL, i.e., the DPPD present in one LDL particle prevented the oxidation of Lipoproteins were isolated as described in Methods, and then oxidized by incubation at 370C for 24 h in F-10 medium containing 10 MM CuS04. Oxidation was measured by the TBARS assay, as described in Methods. Unoxidized lipoproteins were mixed with F-I0 and then subjected to the TBARS assay. Values are means±SEM.
another LDL particle. Human LDL was subjected to copper oxidation in the presence of various concentrations of (a) authentic DPPD, (b) control rabbit LDL, or (c) LDL from DPPD- fed rabbits. The data are presented in Fig. 4 . Increasing amounts of control rabbit LDL led to increasing amounts of TBARS per milliliter, because the rabbit LDL is oxidized along with the human LDL. DPPD itself, and LDL from DPPD-fed rabbits, both block oxidation of human LDL, at similar total concentrations ofDPPD. These results show that either DPPD is rapidly exchanged between lipoproteins, or that DPPD in lipoproteins can terminate lipid peroxidation events occurring outside the particle itself. Effect ofDPPD feeding on atherosclerosis. DPPD feeding decreased lesion area in the thoracic aorta by 71% (P = 0.0007) and decreased total cholesterol content of the aorta by 51% (P = 0.007) (Table IV) . Both cholesteryl ester and free cholesterol content were lower in the DPPD-fed rabbits (Table IV) . Fig. 5 shows a scatter plot of lesion area versus cholesterol exposure (area under the curve of plasma cholesterol with time) for all the rabbits. DPPD-fed rabbits were clearly protected from atherosclerosis compared to controls. There was a large range in severity of atherosclerosis within the control group; this phenomenon has been discussed by Henry (48) .
Discussion
We have shown that the antioxidant DPPD effectively inhibits the oxidative modification ofLDL, with an ECo value 10-100 times lower than that of probucol or BHT. Lipoproteins from rabbits fed DPPD were much more resistant to oxidation than lipoproteins from control rabbits. DPPD feeding also resulted in reduced severity ofatherosclerosis in cholesterol-fed rabbits, without affecting plasma cholesterol levels. We chose to test DPPD as a potential antiatherosclerotic agent purely on the basis of its antioxidant activity. DPPD feeding did not have dramatic effects on lipid metabolism, but it significantly decreased the extent of atherosclerosis. Our ob servations strongly support the oxidized LDL hypothesis of atherosclerosis as proposed by Steinberg and colleagues (6) . Recently Bjorkhem et al. (49) reported that feeding the antioxidant BHT decreased atherosclerotic lesion area in cholesterolfed rabbits. In that study, lipoproteins isolated from the BHTfed rabbits were not more resistant to oxidation than lipoproteins from control animals (49) , so it is difficult to directly correlate the anti-atherosclerotic effect ofBHT with protection of LDL from oxidation.
It has been widely suggested that the antiatherosclerotic activity of probucol is related to its antioxidant activity (6, (21) (22) (23) . Very recently, however, the probucol analogue MDL 29,31 1 was shown to be comparable to probucol with respect to antioxidant activity, but had much less antiatherosclerotic activity than probucol (24) . This implies that some portion ofthe antiatherosclerotic activity ofprobucol is due to other pharmacologic actions. DPPD is a much more potent antioxidant than probucol (Table I) , and therefore presumably much more po- (Table II) . Elevated HDL cholesterol levels are widely believed to be antiatherosclerotic (4) . In cholesterol-fed diabetic rabbits, dramatically elevated triglyceride levels correlate with decreased severity ofatherosclerosis (50) . The small differences in HDL and triglyceride between the groups in our study are probably insufficient to explain the large differences in severity of atherosclerosis. Furthermore, within each ofthe two treatment groups, neither HDL cholesterol level nor triglyceride levels correlated with extent ofatherosclerosis. Despite these observations, we cannot completely exclude the possibilities that DPPD is antiatherosclerotic because it alters lipid metabolism in some subtle fashion or because it influences cellular processing of lipoproteins or cholesterol.
A substantial portion ofthe plasma cholesterol in the cholesterol-fed rabbit is in ,3-migrating very low density lipoprotein (fl-VLDL) (37) . This abnormal lipoprotein has been suggested to be intrinsically atherogenic because cultured macrophages accumulate cholesterol when incubated with ,3-VLDL (51) . This has led to the suggestion that lipoprotein oxidation does not play a role in atherosclerosis in cholesterol-fed rabbits. At least three lines of evidence, however, imply that lipoprotein oxidation is important in this disease model: (a) Previous studies have shown that rabbit fl-VLDL is susceptible to oxidation and the oxidized form is recognized by the macrophage scavenger receptor (52) . We also found that the d < 1.019 lipoprotein fraction, which would be predominantly fl-VLDL, is susceptible to oxidation (Table III) . Oxidized LDL can cause the production of cytokines (14, 53) and is chemotactic for monocytes (11, 52) , and these effects might also be mediated by oxidized fl-VLDL. The recent study using BHT (49) , and the present work with DPPD, show that antioxidants can decrease atherosclerosis in the cholesterol-fed rabbit. Taken together, the evidence suggests that lipoprotein oxidation is an important part of atherogenesis in cholesterol-fed rabbits.
The growing evidence in support of the oxidized LDL hypothesis has led to discussions of possible clinical trials of antioxidants (55) . We have now shown that DPPD is a potent antioxidant and is anti-atherosclerotic in rabbits. Unfortunately, DPPD could never be given to patients because it is a mutagen: DPPD caused chromosome rearrangements in cultured cells (56) , and it was positive in the Ames test for mutagens (57) . Therapeutic use ofpotent antioxidants to treat vascular disease must await the discovery of nontoxic antioxidants.
